(2S)-2-acetamido-6-amino-N-[(2S)-5-(diaminomethylideneamino)-1-oxo-1-[2-[4-[4-[1-[2-oxo-2-(6-oxo-5H-benzo[b][1,4]benzodiazepin-11-yl)ethyl]piperidin-4-yl]butyl]piperazin-1-yl]ethylamino]pentan-2-yl]hexanamide;pentakis(2,2,2-trifluoroacetic acid)

C54H73F15N12O15 — CID 155550631

IUPAC(2S)-2-acetamido-6-amino-N-[(2S)-5-(diaminomethylideneamino)-1-oxo-1-[2-[4-[4-[1-[2-oxo-2-(6-oxo-5H-benzo[b][1,4]benzodiazepin-11-yl)ethyl]piperidin-4-yl]butyl]piperazin-1-yl]ethylamino]pentan-2-yl]hexanamide;pentakis(2,2,2-trifluoroacetic acid)
SMILESCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCCN1CCN(CCCCC2CCN(CC(=O)N3c4ccccc4NC(=O)c4ccccc43)CC2)CC1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F
InChIInChI=1S/C44H68N12O5.5C2HF3O2/c1-32(57)50-37(14-6-8-20-45)43(61)52-36(15-10-21-49-44(46)47)42(60)48-22-26-54-29-27-53(28-30-54)23-9-7-11-33-18-24-55(25-19-33)31-40(58)56-38-16-4-2-12-34(38)41(59)51-35-13-3-5-17-39(35)56;5*3-2(4,5)1(6)7/h2-5,12-13,16-17,33,36-37H,6-11,14-15,18-31,45H2,1H3,(H,48,60)(H,50,57)(H,51,59)(H,52,61)(H4,46,47,49);5*(H,6,7)/t36-,37-;;;;;/m0...../s1
InChIKeyFPYAQRXRBVHTRN-NAVQYVAVSA-N
MW1415.22 g/mol
LogP4.87
Rot. Bonds22

About (2S)-2-acetamido-6-amino-N-[(2S)-5-(diaminomethylideneamino)-1-oxo-1-[2-[4-[4-[1-[2-oxo-2-(6-oxo-5H-benzo[b][1,4]benzodiazepin-11-yl)ethyl]piperidin-4-yl]butyl]piperazin-1-yl]ethylamino]pentan-2-yl]hexanamide;pentakis(2,2,2-trifluoroacetic acid)

(2S)-2-acetamido-6-amino-N-[(2S)-5-(diaminomethylideneamino)-1-oxo-1-[2-[4-[4-[1-[2-oxo-2-(6-oxo-5H-benzo[b][1,4]benzodiazepin-11-yl)ethyl]piperidin-4-yl]butyl]piperazin-1-yl]ethylamino]pentan-2-yl]hexanamide;pentakis(2,2,2-trifluoroacetic acid) (PubChem CID 155550631) has the molecular formula C54H73F15N12O15 and a molecular weight of 1415.22 g/mol. Its IUPAC name is (2S)-2-acetamido-6-amino-N-[(2S)-5-(diaminomethylideneamino)-1-oxo-1-[2-[4-[4-[1-[2-oxo-2-(6-oxo-5H-benzo[b][1,4]benzodiazepin-11-yl)ethyl]piperidin-4-yl]butyl]piperazin-1-yl]ethylamino]pentan-2-yl]hexanamide;pentakis(2,2,2-trifluoroacetic acid).

Molecular Properties

Compound Name(2S)-2-acetamido-6-amino-N-[(2S)-5-(diaminomethylideneamino)-1-oxo-1-[2-[4-[4-[1-[2-oxo-2-(6-oxo-5H-benzo[b][1,4]benzodiazepin-11-yl)ethyl]piperidin-4-yl]butyl]piperazin-1-yl]ethylamino]pentan-2-yl]hexanamide;pentakis(2,2,2-trifluoroacetic acid)
PubChem CID155550631
Molecular FormulaC54H73F15N12O15
Molecular Weight1415.22 g/mol
Exact Mass1414.51
IUPAC Name(2S)-2-acetamido-6-amino-N-[(2S)-5-(diaminomethylideneamino)-1-oxo-1-[2-[4-[4-[1-[2-oxo-2-(6-oxo-5H-benzo[b][1,4]benzodiazepin-11-yl)ethyl]piperidin-4-yl]butyl]piperazin-1-yl]ethylamino]pentan-2-yl]hexanamide;pentakis(2,2,2-trifluoroacetic acid)
SMILESCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCCN1CCN(CCCCC2CCN(CC(=O)N3c4ccccc4NC(=O)c4ccccc43)CC2)CC1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F
InChIInChI=1S/C44H68N12O5.5C2HF3O2/c1-32(57)50-37(14-6-8-20-45)43(61)52-36(15-10-21-49-44(46)47)42(60)48-22-26-54-29-27-53(28-30-54)23-9-7-11-33-18-24-55(25-19-33)31-40(58)56-38-16-4-2-12-34(38)41(59)51-35-13-3-5-17-39(35)56;5*3-2(4,5)1(6)7/h2-5,12-13,16-17,33,36-37H,6-11,14-15,18-31,45H2,1H3,(H,48,60)(H,50,57)(H,51,59)(H,52,61)(H4,46,47,49);5*(H,6,7)/t36-,37-;;;;;/m0...../s1
InChIKeyFPYAQRXRBVHTRN-NAVQYVAVSA-N
XLogP4.87
TPSA423.35 Ų
H-Bond Donors12
H-Bond Acceptors15
Rotatable Bonds22
Heavy Atoms96
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001415.22
LogP ≤ 54.87
H-Bond Donors ≤ 512
H-Bond Acceptors ≤ 1015

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'imine_2', 'substructure': 'N/A'}

Analyze (2S)-2-acetamido-6-amino-N-[(2S)-5-(diaminomethylideneamino)-1-oxo-1-[2-[4-[4-[1-[2-oxo-2-(6-oxo-5H-benzo[b][1,4]benzodiazepin-11-yl)ethyl]piperidin-4-yl]butyl]piperazin-1-yl]ethylamino]pentan-2-yl]hexanamide;pentakis(2,2,2-trifluoroacetic acid) with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of (2S)-2-acetamido-6-amino-N-[(2S)-5-(diaminomethylideneamino)-1-oxo-1-[2-[4-[4-[1-[2-oxo-2-(6-oxo-5H-benzo[b][1,4]benzodiazepin-11-yl)ethyl]piperidin-4-yl]butyl]piperazin-1-yl]ethylamino]pentan-2-yl]hexanamide;pentakis(2,2,2-trifluoroacetic acid)?
The IUPAC name of (2S)-2-acetamido-6-amino-N-[(2S)-5-(diaminomethylideneamino)-1-oxo-1-[2-[4-[4-[1-[2-oxo-2-(6-oxo-5H-benzo[b][1,4]benzodiazepin-11-yl)ethyl]piperidin-4-yl]butyl]piperazin-1-yl]ethylamino]pentan-2-yl]hexanamide;pentakis(2,2,2-trifluoroacetic acid) (CID 155550631) is (2S)-2-acetamido-6-amino-N-[(2S)-5-(diaminomethylideneamino)-1-oxo-1-[2-[4-[4-[1-[2-oxo-2-(6-oxo-5H-benzo[b][1,4]benzodiazepin-11-yl)ethyl]piperidin-4-yl]butyl]piperazin-1-yl]ethylamino]pentan-2-yl]hexanamide;pentakis(2,2,2-trifluoroacetic acid).
What is the SMILES notation for (2S)-2-acetamido-6-amino-N-[(2S)-5-(diaminomethylideneamino)-1-oxo-1-[2-[4-[4-[1-[2-oxo-2-(6-oxo-5H-benzo[b][1,4]benzodiazepin-11-yl)ethyl]piperidin-4-yl]butyl]piperazin-1-yl]ethylamino]pentan-2-yl]hexanamide;pentakis(2,2,2-trifluoroacetic acid)?
The canonical SMILES for (2S)-2-acetamido-6-amino-N-[(2S)-5-(diaminomethylideneamino)-1-oxo-1-[2-[4-[4-[1-[2-oxo-2-(6-oxo-5H-benzo[b][1,4]benzodiazepin-11-yl)ethyl]piperidin-4-yl]butyl]piperazin-1-yl]ethylamino]pentan-2-yl]hexanamide;pentakis(2,2,2-trifluoroacetic acid) is CC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCCN1CCN(CCCCC2CCN(CC(=O)N3c4ccccc4NC(=O)c4ccccc43)CC2)CC1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.
What is the InChIKey of (2S)-2-acetamido-6-amino-N-[(2S)-5-(diaminomethylideneamino)-1-oxo-1-[2-[4-[4-[1-[2-oxo-2-(6-oxo-5H-benzo[b][1,4]benzodiazepin-11-yl)ethyl]piperidin-4-yl]butyl]piperazin-1-yl]ethylamino]pentan-2-yl]hexanamide;pentakis(2,2,2-trifluoroacetic acid)?
The InChIKey is FPYAQRXRBVHTRN-NAVQYVAVSA-N. The full InChI is InChI=1S/C44H68N12O5.5C2HF3O2/c1-32(57)50-37(14-6-8-20-45)43(61)52-36(15-10-21-49-44(46)47)42(60)48-22-26-54-29-27-53(28-30-54)23-9-7-11-33-18-24-55(25-19-33)31-40(58)56-38-16-4-2-12-34(38)41(59)51-35-13-3-5-17-39(35)56;5*3-2(4,5)1(6)7/h2-5,12-13,16-17,33,36-37H,6-11,14-15,18-31,45H2,1H3,(H,48,60)(H,50,57)(H,51,59)(H,52,61)(H4,46,47,49);5*(H,6,7)/t36-,37-;;;;;/m0...../s1.
What are the key properties of (2S)-2-acetamido-6-amino-N-[(2S)-5-(diaminomethylideneamino)-1-oxo-1-[2-[4-[4-[1-[2-oxo-2-(6-oxo-5H-benzo[b][1,4]benzodiazepin-11-yl)ethyl]piperidin-4-yl]butyl]piperazin-1-yl]ethylamino]pentan-2-yl]hexanamide;pentakis(2,2,2-trifluoroacetic acid)?
(2S)-2-acetamido-6-amino-N-[(2S)-5-(diaminomethylideneamino)-1-oxo-1-[2-[4-[4-[1-[2-oxo-2-(6-oxo-5H-benzo[b][1,4]benzodiazepin-11-yl)ethyl]piperidin-4-yl]butyl]piperazin-1-yl]ethylamino]pentan-2-yl]hexanamide;pentakis(2,2,2-trifluoroacetic acid) has a molecular weight of 1415.22 g/mol, XLogP of 4.87, 22 rotatable bonds, 12 hydrogen bond donors, and 15 hydrogen bond acceptors.
Where does this data come from?
All data for (2S)-2-acetamido-6-amino-N-[(2S)-5-(diaminomethylideneamino)-1-oxo-1-[2-[4-[4-[1-[2-oxo-2-(6-oxo-5H-benzo[b][1,4]benzodiazepin-11-yl)ethyl]piperidin-4-yl]butyl]piperazin-1-yl]ethylamino]pentan-2-yl]hexanamide;pentakis(2,2,2-trifluoroacetic acid) is sourced from PubChem (CID 155550631), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).